IN2012DN01695A - - Google Patents

Download PDF

Info

Publication number
IN2012DN01695A
IN2012DN01695A IN1695DEN2012A IN2012DN01695A IN 2012DN01695 A IN2012DN01695 A IN 2012DN01695A IN 1695DEN2012 A IN1695DEN2012 A IN 1695DEN2012A IN 2012DN01695 A IN2012DN01695 A IN 2012DN01695A
Authority
IN
India
Prior art keywords
capsular polysaccharides
provides
neisseria meningitidis
capsular
polysaccharides
Prior art date
Application number
Other languages
English (en)
Inventor
Rita Gerardy-Schahn
Martina Muhlenhoff
Andrea Bethe
Katharina Stummeyer
Friedrich Freiberger
Sebastian Damerow
Original Assignee
Hannover Med Hochschule
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hannover Med Hochschule filed Critical Hannover Med Hochschule
Publication of IN2012DN01695A publication Critical patent/IN2012DN01695A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/095—Neisseria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10—Transferases (2.)
    • C12N9/12—Transferases (2.) transferring phosphorus containing groups, e.g. kinases (2.7)
    • C12N9/1241—Nucleotidyltransferases (2.7.7)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/04—Polysaccharides, i.e. compounds containing more than five saccharide radicals attached to each other by glycosidic bonds
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/18—Preparation of compounds containing saccharide radicals produced by the action of a glycosyl transferase, e.g. alpha-, beta- or gamma-cyclodextrins

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IN1695DEN2012 2009-08-26 2010-08-26 IN2012DN01695A (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP09168765 2009-08-26
PCT/EP2010/062481 WO2011023764A1 (en) 2009-08-26 2010-08-26 Means and methods for producing artificial capsular polysaccharides of neisseria meningitidis

Publications (1)

Publication Number Publication Date
IN2012DN01695A true IN2012DN01695A (de) 2015-06-05

Family

ID=43086450

Family Applications (1)

Application Number Title Priority Date Filing Date
IN1695DEN2012 IN2012DN01695A (de) 2009-08-26 2010-08-26

Country Status (8)

Country Link
US (1) US20130012471A1 (de)
EP (1) EP2470203A1 (de)
CN (1) CN102596241A (de)
BR (1) BR112012007877A2 (de)
CA (1) CA2771672A1 (de)
IN (1) IN2012DN01695A (de)
RU (1) RU2012111424A (de)
WO (1) WO2011023764A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2852414B9 (de) * 2012-05-22 2020-12-09 GlaxoSmithKline Biologicals SA Meningokokken-serogruppe-x-konjugat
EP3131576B1 (de) * 2014-04-17 2021-06-30 Medizinische Hochschule Hannover Mittel und verfahren zur herstellung von neisseria meningitidis kapsel-polysacchariden mit geringer dispersität
US10307474B2 (en) * 2014-08-08 2019-06-04 Glaxosmithkline Biologicals S.A. Modified host cells and hybrid oligosaccharides for use in bioconjugate production
ES2846794T3 (es) * 2014-11-18 2021-07-29 Pasteur Institut Anticuerpos policlonales específicos para el serogrupo X de N. meningitidis y usos de los mismos en el diagnóstico
US20200030430A1 (en) * 2015-07-01 2020-01-30 Glaxosmithkline Biologicals Sa Immunogenic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4711955A (en) 1981-04-17 1987-12-08 Yale University Modified nucleotides and methods of preparing and using same
CA1223831A (en) 1982-06-23 1987-07-07 Dean Engelhardt Modified nucleotides, methods of preparing and utilizing and compositions containing the same
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
US5792608A (en) 1991-12-12 1998-08-11 Gilead Sciences, Inc. Nuclease stable and binding competent oligomers and methods for their use
US5525711A (en) 1994-05-18 1996-06-11 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services Pteridine nucleotide analogs as fluorescent DNA probes
CN1401774A (zh) * 2002-07-19 2003-03-12 大连理工大学 一种尿苷二磷酸葡萄糖焦磷酸化酶基因及其克隆

Also Published As

Publication number Publication date
US20130012471A1 (en) 2013-01-10
CA2771672A1 (en) 2011-03-03
CN102596241A (zh) 2012-07-18
EP2470203A1 (de) 2012-07-04
RU2012111424A (ru) 2013-10-10
BR112012007877A2 (pt) 2019-09-24
WO2011023764A1 (en) 2011-03-03

Similar Documents

Publication Publication Date Title
BR112012007876A2 (pt) "membranas de troca de íons"
IN2014DN09791A (de)
AU2016204319A1 (en) Methods and compositions for producing squalene using yeast
SG10201808050YA (en) BIOTECHNOLOGICAL PRODUCTION OF LNT, LNnT AND THE FUCOSYLATED DERIVATIVES THEREOF
MX2013008850A (es) Composiciones y metodos para tratar enfermedades cardiovasculares.
EP2433647A3 (de) Gna1870-basierte vesikelimpfstoffe für breitbandschutz gegen neisseria meningitidis-bedingte erkrankungen
GB0900127D0 (en) Method of producing miningococcal meningitis vaccine for neisseria menningitis serotyes A, C, Y and W-135
MX2009008928A (es) Composiciones que comprenden conjugados de polisacaridos y su uso como vacunas.
MY163889A (en) Wellbore servicing compositions and methods of making and using same
WO2010000127A9 (en) Method to induce and expand therapeutic alloantigen- specific human regulatory t cells in large-scale
IN2012DN01695A (de)
NZ595223A (en) Combinations including pneumococcal serotype 14 saccharide
PH12015500497A1 (en) Production method for capsular polysaccharide having pneumococcal serotype
WO2015066668A8 (en) Methods of removing alpha-galactose
MX2014014576A (es) Vacunas para meningococo de serogrupo x.
MY199399A (en) Novel polysaccharide-protein conjugates and process to obtain thereof
GB0503936D0 (en) Method
WO2018042017A3 (en) Vaccines for neisseria gonorrhoeae
BRPI0918226A2 (pt) composição imunogênica, método para produzir uma composição imunogênica, método para elicitar uma resposta imune contra neisseria, uso da composição imunogênica, e, vacina
MY156694A (en) Producing edible residues from ethanol production
EP4232158A4 (de) Zusammensetzungen und verfahren zur impfung gegen neisseria gonorrhoeae
WO2010129457A3 (en) Vaccines against tularemia
AU2012262554A8 (en) Extracellular matrix material conduits and methods of making and using same
WO2010110931A3 (en) Glycoconjugate vaccines
WO2015158898A3 (en) Means and methods for producing neisseria meningitidis capsular polysaccharides of low dispersity